Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial von MARTINS, Renato G, PARVATHANENI, Upendra, MENDEZ, Eduardo, FUTRAN, Neal, WANG, David X, XIAOYU CHAI, WALLACE, Sarah G, AUSTIN, Melissa, SCHMIDT, Rodney, HAYES, D. Neil, BAUMAN, Julie E, SHARMA, Anand K, RAEZ, Luis E, PAPAGIKOS, Michael A, YUNUS, Furhan, KURLAND, Brenda F, EATON, Keith D, LIAO, Jay J

Volltext

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Ther... von Movsas, Benjamin, Rodgers, Joseph P, Elshaikh, Mohamed A, Martinez, Alvaro A, Morton, Gerard C, Krauss, Daniel J, Yan, Di, Citrin, Deborah E, Hershatter, Bruce W, Michalski, Jeff M, Ellis, Rodney J, Kavadi, Vivek S, Gore, Elizabeth M, Gustafson, Gary S, Schulz, Craig A, Velker, Vikram M, Olson, Adam C, Cury, Fabio L, Papagikos, Michael A, Karrison, Theodore G, Sandler, Howard M, Bruner, Deborah W

Volltext

Toxicity and quality of life report of a phase II study of stereotactic body radiotherapy (SBRT) for low and intermediate risk prostate cancer von Boyer, Matthew J, Papagikos, Michael A, Kiteley, Rex, Vujaskovic, Zeljko, Wu, Jackie, Lee, W Robert

Volltext

Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial von Michalski, Jeff M, Winter, Kathryn A, Prestidge, Bradley R, Sanda, Martin G, Amin, Mahul, Bice, William S, Gay, Hiram A, Ibbott, Geoffrey S, Crook, Juanita M, Catton, Charles N, Raben, Adam, Bosch, Walter, Beyer, David C, Frank, Steven J, Papagikos, Michael A, Rosenthal, Seth A, Barthold, H Joseph, Roach, 3rd, Mack, Moughan, Jennifer, Sandler, Howard M

Volltext

Carolina Hurricanes von Royce, Trevor J., Papagikos, Michael A., Maguire, Patrick D., Marks, Lawrence B.

Volltext

Cardiovascular Preventive Care and Coordination of Care in Prostate Cancer Survivors: A Multi-Institutional Prospective Study von Holmes, Jordan A., Anderson, Roger F., Hoffman, Leroy G., Showalter, Timothy N., Kasibhatla, Mohit, Collins, Sean P., Papagikos, Michael A., Barbosa, Brittany D., Alligood, Kristy, Stravers, Lori J., Mahbooba, Zahra, Wang, Andrew Z., Chen, Ronald C.

Volltext

Lessons learned from randomised clinical trials in adult low grade glioma von Papagikos, Michael A, Shaw, Edward G, Stieber, Volker W

Volltext

Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer von Rossi, Peter J., Clark, Peter E., Papagikos, Michael A., McCullough, David L., Lee, W. Robert

Volltext

Publication rate of abstracts from the annual ASTRO meeting: Comparison with other organizations von Papagikos, Michael A., Rossi, Peter J., Lee, W. Robert

Volltext

A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone von Papagikos, Michael A, Rossi, Peter J, Urbanic, James J, deGuzman, Allan F, McCullough, David L, Clark, Peter E, Lee, W Robert

Volltext

Applying dosimetric benchmarks to low-dose-rate prostate brachytherapy in the community setting: Ready for prime time? von Papagikos, Michael A., M.D, Maguire, Patrick D., M.D, Neal, Charles R., M.D, Meyerson, Martin B., M.D., FACRO, Urquhart, H. Scott, MM.SC, Nichols, R. Vance, M.D, Russell, William, M.D, Bennett, Robert T., M.D., FAAP

Volltext

Perceptions on coordination of care in prostate cancer patients treated with radiotherapy (RT) and androgen deprivation therapy (ADT): Implications for survivorship care planning von Holmes, Jordan A., Anderson, Roger F., Hoffman, Leroy G., Showalter, Timothy Norman, Kasibhatla, Mohit S., Collins, Sean P., Papagikos, Michael A., Barbosa, Brittney Diane, Stravers, Lori, Mahbooba, Zahra, Wang, Andrew, Chen, Ronald C.

Volltext

Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90? von Papagikos, Michael A., deGuzman, Allan F., Rossi, Peter J., McCullough, David L., Clark, Peter E., Lee, W. Robert

Volltext

Expression of p16, ERCC1, and EGFR amplification as predictors of responsiveness of locally advanced squamous cell carcinomas of head and neck (SCCHN) to cisplatin, radiotherapy, a... von Austin, Melissa, Schmidt, Rodney, Parvathaneni, Upendra, Bauman, Julie E., Hayes, David N., Papagikos, Michael A., Eaton, Keith D., Liao, Jay Justin, Mendez, Eduardo, Kurland, Brenda F, Xiaoyu, Shawn, Wallace, Sarah G., Martins, Renato

Volltext

Randomized phase II trial of cisplatin and radiotherapy with or without erlotinib in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) von Martins, Renato, Parvathaneni, Upendra, Sharma, Anand K., Raez, Luis E., Papagikos, Michael A., Yunus, Furhan, Bauman, Julie E., Eaton, Keith D., Liao, Jay Justin, Mendez, Eduardo, Futran, Neal, Kurland, Brenda F, Wang, David X., Xiaoyu, Shawn, Wallace, Sarah G., Hayes, David N.

Volltext

Commentary (Papagikos/Lee): Permanent Prostate Brachytherapy von Papagikos, Michael A, Lee, W Robert

Volltext

Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V 100 superior to D 90? von Papagikos, Michael A., deGuzman, Allan F., Rossi, Peter J., McCullough, David L., Clark, Peter E., Lee, W. Robert

Volltext

Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)? von Papagikos, Michael A, Deguzman, Allan F, Rossi, Peter J, McCullough, David L, Clark, Peter E, Lee, W Robert

Volltext

Phase II Trial of Hyperfractionated Intensity-Modulated Radiation Therapy and Concurrent Weekly Cisplatin for Stage III and IVa Head-and-Neck Cancer von Maguire, Patrick D., M.D, Papagikos, Michael, M.D, Hamann, Sue, Ph.D, Neal, Charles, M.D, Meyerson, Martin, M.D, Hayes, Neil, M.D, Ungaro, Peter, M.D, Kotz, Kenneth, M.D, Couch, Marion, M.D, Pollock, Hoke, M.D, Tepper, Joel, M.D

Volltext

Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer von Petty, W. Jeffrey, Urbanic, James J., Ahmed, Tamjeed, Hughes, Ryan, Levine, Beverly, Rusthoven, Kyle, Papagikos, Michael, Ruiz, Jimmy R., Lally, Brian E., Chan, Michael, Clark, Hollins, D'Agostino, Ralph B., Blackstock, A. William

Volltext